Lunch & Learn Roundtable Discussion
VECTOR VIGNETTES – RESILIENCE VIRAL VECTOR MANUFACTURING TECHNOLOGIES
John Kerwin, Technical Head, Gene Therapy
Speaker Bio:
John Kerwin is the Technical Head of the Gene Therapy Franchise at Resilience. He is responsible for process and analytical development and technology for viral vectors, used both for in vitro and in vivo applications.
He was previously leading Gene Therapy Manufacturing Sciences for Biogen where he was responsible for late-stage process development and validation of ocular and CNS-directed, AAV-based gene therapies. Prior, he built and directed a viral vector and therapeutic protein core facility at the University of Maryland and was a process development engineer at AERAS Global TB Vaccine foundation developing viral vector-based and live vaccines. John holds a PhD in Chemical Engineering from the University of Maryland-College Park.
